US2008305057A1PendingUtilityA1
New and improved skin treatment systems
Assignee: DAMAGE CONTROL TECHNOLOGIES INPriority: Jun 7, 2007Filed: Jun 7, 2007Published: Dec 11, 2008
Est. expiryJun 7, 2027(~0.9 yrs left)· nominal 20-yr term from priority
Inventors:Charles L. Fox, Jr.
A61K 8/90A61K 8/64A61K 8/68A61Q 17/04A61Q 19/08
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A basic facial and body treatment cosmetic formulation is a combination of a cationic emulsifying agent, an oil soluble liquid polymer and a naturally occurring lactate buffer system. The basic formulation is a starter system that can be specialized to skin moisturizers, skin lighteners, skin pigmenting agents, sunscreens, antioxidants, line reducing products, wrinkle reducing products, anti-cellulite products, pharmaceuticals and the like.
Claims
exact text as granted — not AI-modified1 . A base formulation, consisting essentially of:
a cationic emulsifying agent 1.50-5.00 % wt; a water insoluble liquid polymer that releases an active material from said base formulation over a period of up to 12 hours 0.510.0 % wt; a lactate, citrate, phosphate, or acetate buffer system quantity sufficient for pH about 4.0-5.0; and water remainder.
2 . A day cream with sunscreen, comprising:
sunscreen
8.0-46.5% wt;
a cationic emulsifying agent
1.00-5.00% wt;
an oil soluble/
1.00-5.00% wt;
dispersible liquid polymer
moisturizing agents
8.6-14.45% wt;
a buffer quantity sufficient to pH
3.8-6.2; and
water
remainder.
3 . The day cream with sunscreen according to claim 2 , wherein said sunscreen includes:
avobenzone
2.00-3.00% wt;
octinoxate
5.00-7.50% wt;
oxybenzone
3.00-6.00% wt;
homosalate
5.00-15.00% wt;
octisalate
2.00-5.00% wt; and
octocrylene
3.00-10.00% wt.
4 . The day cream with sunscreen according to claim 2 , wherein said cationic emulsifying agent is selected from the group consisting of steapyrium chloride, behetrimonium chloride, dicetyldimonium chloride, and distearyldimonium chloride.
5 . The day cream with sunscreen according to claim 2 , wherein said oil soluble/dispersible liquid polymer includes:
PPG-12 SMDI copolymer
1.00-5.00% wt; and
PPG-51 SMDI copolymer
0.10-0.75% wt.
6 . The day cream with sunscreen according to claim 2 , wherein said oil soluble/dispersible liquid polymer is selected from the group consisting of water insoluble carbomers, water insoluble cellulosics, water insoluble clays, water insoluble polyacrylates, polyolprepolymer-2, polyolprepolymer-14, polyolprepolymer-15, and liquid polymers.
7 . The day cream with sunscreen according to claim 2 , wherein said moisturizing agents include:
glyceryl stearate
1.45-3.00% wt;
isocetyl stearate
1.75-3.00% wt;
squalane
1.45-3.00% wt;
sodium hyaluronate (1%)
1.35-5.00% wt;
sodium PCA
1.25-3.00% wt; and
saccharide isomerate
1.35-3.00% wt.
8 . The day cream with sunscreen according to claim 2 , further comprising:
a fatty alcohol
1.00-3.00% wt.
9 . The day cream with sunscreen according to claim 2 , further comprising:
antioxidants
1.65-2.5% wt.
10 . The day cream with sunscreen according to claim 9 , wherein said antioxidants include:
superoxide dismutase
0.10-1.25% wt; and
green tea extract
0.75-1.25% wt.
11 . The day cream with sunscreen according to claim 9 , wherein said antioxidants are selected from the group consisting of green tea extract, ginko nut extract, grape seed extract, superoxide dismutase, vitamin A, vitamin C, and vitamin E.
12 . The day cream with sunscreen according to claim 2 , wherein said buffer is selected from the group consisting of phosphate buffers, citrate buffers, lactate buffers and water soluble buffers.
13 . The day cream with sunscreen according to claim 2 ,
further comprising:
phenoxyethanol
0.20-1.00% wt;
methylparaben
0.10-0.75% wt;
butylparaben
0.10-0.65% wt;
propylparaben
0.05-0.55% wt; and
iodopropynyl butyl carbamate
0.10-0.65% wt.
14 . A day cream with sunscreen, comprising:
avobenzone
2.7-3.0% wt;
octinoxate
7.0-7.50% wt;
oxybenzone
5.5-6.00% wt;
PPG-12 SMDI copolymer
1.00-5.00% wt;
PPG-51 SMDI copolymer
0.10-0.75% wt;
steapyrium chloride
1.00-3.00% wt;
glyceryl stearate
1.45-3,50% wt;
cetyl alcohol
1.00-2.50% wt;
isocetyl stearate
1.00-3.00% wt;
squalane
1.00-5.00% wt;
sodium hyaluronate (1%)
1.00-5.00% wt;
sodium PCA
1.00-5.00% wt;
saccharide isomerate
1.00-5.00% wt;
superoxide dismutase
0.05-1.50% wt;
green tea extract
0.75-3.00% wt;
phenoxyethanol
0.20-1.00% wt;
methylparaben
0.10-0.75% wt;
butylparaben
0.10-0.65% wt;
isopropylparaben
0.05-0.55% wt;
iodopropynyl butyl carbamate
0.10-0.65% wt;
lactate buffer qs to pH
3.8-6.2; and
water
remainder.
15 . A wrinkle cream, comprising:
a cationic emulsifying agent
1.50-5.00% wt;
an oil soluble liquid polymer
1.00-5.00% wt;
anti-wrinkle agents
2.05-8.00% wt;
a buffer quantity sufficient to pH
3.9-6.0; and
water
remainder.
16 . The wrinkle cream according to claim 15 , wherein said anti-wrinkle agents includes:
palmitoyl pentapeptide-4
0.65-2.00% wt;
palmitoyl tetraoeoptide-7
0.75-2.00% wt;
ceramide 2
0.30-0.85% wt; and
palmitoyl oligopeptide
0.35-1.00% wt.
17 . The wrinkle cream according to claim 15 , wherein said anti-wrinkle agents are selected from the group consisting of ceramide 2, PEG-10 rapeseed sterol, palmitoyl oligopeptide, and palmitoyl tetrapeptide-7.
18 . The wrinkle cream according to claim 15 , wherein said cationic emulsifying agent is selected from the group consisting of steapyrium chloride, behetrimonium chloride, dicetyldimonium chloride, and distearyldimonium chloride.
19 . The wrinkle cream according to claim 15 , wherein said oil soluble liquid polymer includes:
PPG-12 SMDI copolymer
1.00-5.00% wt; and
PPG-51 SMDI copolymer
0.10-0.50% wt.
20 . The wrinkle according to claim 15 , wherein said oil soluble liquid polymer is selected from the group consisting of water insoluble carbomers, water insoluble cellulosics, water insoluble clays, water insoluble polyacrylates, polyolprepolymer-2, polyolprepolymer-14, polyolprepolymer-15, and liquid polymers.
21 . The wrinkle cream according to claim 15 , further comprising:
moisturizing agents
4.10-7.64% wt; and
antioxidants
0.20-1.25% wt.
22 . The wrinkle cream according to claim 21 , wherein said moisturizing agents include:
glcyceryl stearate
1.00-3.00% wt;
jojoba oil
0.65-3.00% wt;
isocetyl stearate
0.65-3.000% wt;
sodium hyaluronate
1.00-5.00% wt; and
sodium PCA
0.75-3.00% wt.
23 . The wrinkle cream according to claim 21 , wherein said antioxidants include:
vitamin A palmitate
0.05-0.50% wt; and
vitamin E acetate
0.10-3.00% wt.
24 . The wrinkle cream according to claim 15 , further comprising:
a fatty alcohol
0.65-3.00% wt.
25 . The wrinkle cream according to claim 15 , wherein said buffer is selected from the group consisting of phosphate buffers, citrate buffers, lactate buffers and water soluble buffers.
26 . A wrinkle cream, comprising:
PPG-12 SMDI copolymer
2.25-3.15% wt;
PPG-51 SMDI copolymer
0.10-0.50% wt;
vitamin A palmitate
0.10-0.50% wt;
vitamin E acetate
0.10-0.75% wt;
glcyceryl stearate
1.75-2.35% wt;
distearyldimmonium chloride
1.70-5.00% wt;
cetyl alcohol
0.75-1.30% wt;
jojoba oil
0.65-1.35% wt;
isocetyl stearate
0.65-3.00% wt;
sodium hyaluronate
0.50-5.00% wt;
sodium PCA
0.75-3.00% wt;
palmitoyl pentapeptide-4
0.65-1.40% wt;
palmitoyl tetraoeoptide-7
0.75-1.20% wt;
ceramide 2
0.30-0.85% wt;
palmitoyl oligopeptide
0.35-0.75% wt;
lactate buffer qs to pH
3.9-6.00; and
water
remainder.Join the waitlist — get patent alerts
Track US2008305057A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.